NZ Rheumatology Research Review Issue 29

In this issue:

Oral glucocorticoids: a risk factor for T2DM in RA
Sustained remission in RA after DMARD therapy
Long-term follow-up of SLE deemed to be crucial
A high prevalence of comorbidities in SpA
bDMARDs: no association with virus-associated cancer
Oral prednisone vs indomethacin in acute gout
Network meta-analysis of analgesics in OA pain relief
Long-term benefits with T2T in RA
High remission rates in real-world DMARD-naïve RA or UA
Consider risk profiles of specific NSAIDs before prescribing

Please login below to download this issue (PDF)